Scott Kuhns

554 total citations
28 papers, 443 citations indexed

About

Scott Kuhns is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Scott Kuhns has authored 28 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 20 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Scott Kuhns's work include Monoclonal and Polyclonal Antibodies Research (21 papers), Biosimilars and Bioanalytical Methods (12 papers) and Protein purification and stability (10 papers). Scott Kuhns is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), Biosimilars and Bioanalytical Methods (12 papers) and Protein purification and stability (10 papers). Scott Kuhns collaborates with scholars based in United States and Canada. Scott Kuhns's co-authors include Larry R. Pease, Shawn Cao, Jennifer Liu, Helen J. McBride, Aaron J. Johnson, Cynthia Li, Lieping Chen, M. Kariuki Njenga, Michael J. Hansen and Moses Rodriguez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Scott Kuhns

28 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Kuhns United States 11 298 218 185 65 34 28 443
Melody Sauerborn Netherlands 9 184 0.6× 307 1.4× 265 1.4× 40 0.6× 9 0.3× 10 441
Anita Kumari India 11 101 0.3× 104 0.5× 56 0.3× 142 2.2× 9 0.3× 48 477
Kashyap Patel United States 12 183 0.6× 196 0.9× 153 0.8× 23 0.4× 5 0.1× 32 372
Chia‐Huey Lin Germany 6 331 1.1× 37 0.2× 29 0.2× 76 1.2× 8 0.2× 7 389
Gennady V. Gololobov Russia 6 199 0.7× 303 1.4× 390 2.1× 28 0.4× 5 0.1× 8 524
David V. Weber United States 12 146 0.5× 201 0.9× 98 0.5× 46 0.7× 14 0.4× 15 399
Д. И. Соколов Russia 13 311 1.0× 222 1.0× 14 0.1× 43 0.7× 52 1.5× 104 562
Hideaki Toki Japan 9 198 0.7× 214 1.0× 14 0.1× 66 1.0× 4 0.1× 12 396
Veronica Juan United States 8 63 0.2× 286 1.3× 163 0.9× 29 0.4× 12 0.4× 9 359

Countries citing papers authored by Scott Kuhns

Since Specialization
Citations

This map shows the geographic impact of Scott Kuhns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Kuhns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Kuhns more than expected).

Fields of papers citing papers by Scott Kuhns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Kuhns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Kuhns. The network helps show where Scott Kuhns may publish in the future.

Co-authorship network of co-authors of Scott Kuhns

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Kuhns. A scholar is included among the top collaborators of Scott Kuhns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Kuhns. Scott Kuhns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seo, Neung‐Seon, et al.. (2024). Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product. Ophthalmology and Therapy. 14(1). 85–101. 1 indexed citations
2.
Seo, Neung‐Seon, Xiaoyan Guan, Tian Wang, et al.. (2024). Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product. Ophthalmology and Therapy. 13(5). 1303–1320. 3 indexed citations
3.
Shah, Bhavana, et al.. (2023). Engineering protein glycosylation in CHO cells to be highly similar to murine host cells. Frontiers in Bioengineering and Biotechnology. 11. 1113994–1113994. 8 indexed citations
4.
Cantin, Greg, Qian Liu, Bhavana Shah, et al.. (2023). Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product. Drugs in R&D. 23(4). 421–438. 8 indexed citations
5.
Guan, Xiaoyan, Marisa K. Joubert, Scott Kuhns, et al.. (2022). State-of-the-art and emerging trends in analytical approaches to pharmaceutical-product commercialization. Current Opinion in Biotechnology. 78. 102800–102800. 4 indexed citations
6.
Duff, R. Joel, et al.. (2021). Fc glycan sialylation of biotherapeutic monoclonal antibodies has limited impact on antibody‐dependent cellular cytotoxicity. FEBS Open Bio. 11(11). 2943–2949. 8 indexed citations
7.
McBride, Helen J., Vincent Chow, Palanisamy Kanakaraj, et al.. (2021). Non-clinical similarity of biosimilar ABP 798 with rituximab reference product. Biologicals. 72. 42–53. 2 indexed citations
8.
Kroenke, Mark A., Jenny Hu, Lidong He, et al.. (2021). Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target. Frontiers in Immunology. 12. 782788–782788. 8 indexed citations
9.
Hutterer, Katariina M., et al.. (2021). Analytical Similarity Assessment of ABP 959 in Comparison with Eculizumab Reference Product. BioDrugs. 35(5). 563–577. 9 indexed citations
10.
Seo, Neung‐Seon, Zhe Huang, Scott Kuhns, et al.. (2020). Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product. Biologicals. 68. 79–91. 13 indexed citations
11.
Kuhns, Scott, et al.. (2020). Differential influence on antibody dependent cellular phagocytosis by different glycoforms on therapeutic Monoclonal antibodies. Journal of Biotechnology. 317. 5–15. 12 indexed citations
12.
Saleem, Ramsey A., Greg Cantin, Mats Wikström, et al.. (2020). Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product. Pharmaceutical Research. 37(6). 114–114. 15 indexed citations
13.
Zhang, Qingchun, Marisa K. Joubert, Alla Polozova, et al.. (2020). Glycan engineering reveals interrelated effects of terminal galactose and core fucose on antibody‐dependent cell‐mediated cytotoxicity. Biotechnology Progress. 36(6). e3045–e3045. 13 indexed citations
14.
Wang, Wei, Heather Sweet, Raffi Manoukian, et al.. (2019). Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab. Pharmaceutical Research. 36(12). 177–177. 15 indexed citations
15.
Hutterer, Katariina M., et al.. (2019). Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab. BioDrugs. 33(3). 321–333. 25 indexed citations
16.
McBride, Helen J., et al.. (2017). Functional Similarity of Proposed Biosimilar ABP 798 with Rituximab. Blood. 130. 5001–5001. 1 indexed citations
17.
Liu, Jennifer, et al.. (2016). Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab. BioDrugs. 30(4). 321–338. 76 indexed citations
18.
Kuhns, Scott, et al.. (2011). Accuracy and sensitivity of residual DNA detection by QPCR is not predicted by target copy number. Biotechnology Progress. 28(2). 428–434. 4 indexed citations
19.
Kuhns, Scott & Gerald F. Joyce. (2003). Perfectly Complementary Nucleic Acid Enzymes. Journal of Molecular Evolution. 56(6). 711–717. 9 indexed citations
20.
Mendez-Fernandez, Yanice, Matthew S. Block, Aaron J. Johnson, et al.. (2002). Enhanced binding of low‐affinity antibodies interacting simultaneously with targeted cell surface molecules and Fc receptor. Tissue Antigens. 60(6). 515–525. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melody Sauerborn Breakdown of academic impact, for papers by Anita Kumari Breakdown of academic impact, for papers by Kashyap Patel Breakdown of academic impact, for papers by Chia‐Huey Lin Breakdown of academic impact, for papers by Gennady V. Gololobov Breakdown of academic impact, for papers by David V. Weber Breakdown of academic impact, for papers by Д. И. Соколов Breakdown of academic impact, for papers by Hideaki Toki Breakdown of academic impact, for papers by Veronica Juan
Rankless by CCL
2026